Login

Keyvan Mohajer, CEO of SoundHound AI, joins 'Power Lunch' to discuss Nvidia's $3.7 million investment in the company.|Keyvan Mohajer, CEO of SoundHound AI 00:10:00

Share On Facebook Share On Twitter

Keyvan Mohajer, CEO of SoundHound AI

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Shibani Kurian Presents Kotak Focused Equity Fund: A Strategy for Select Focus Investing | Shibani Kurian, Head of Research & Equity Fund Manager, Kotak Mutual Fund
00:00:00
Michael K. McGarrity Chief Executive Officer, Director, MDxHealth
00:10:00
Reflecting on Romania's Energy Future: Lessons Learned and Ambitious Plans Ahead | Georgeta Corina Popescu, CEO , Societatea Energetica Electrica SA.
00:00:00
Alligator Bioscience | May 2023 - Søren Bregenholt , CEO, Alligator Bioscience
00:10:00
Venture capital firm on a mission to diversify the face of wealth|Diana Murakhovskaya,Co-Founder and General Partner,The Artemis Fund
00:10:00
Leading with Optimism and a Vision for Global Impact | Roberto Funari, CEO , Alpargatas SA.
00:10:00
Navigating the cannabis industry's evolution and Avant Brands' strategic growth insights from CEO Norton| Gregory J. Divis, CEO, Avant Brands Inc.
00:10:00
Sarama Resources: Regaining Control and Advancing Gold Exploration in West Africa
00:10:00
Unlocking Tomorrow's Opportunities: Teo Dechev's Insights at the 2023 Rule Symposium | Teo Dechev - CEO of Mundoro Capital Inc.
00:10:00
venture capital is the only asset class where the asset chooses the investor|Abie J Cohen,General Partner,Centre Street Partners
00:10:00
Navigating Hedge Fund Startups: Insights on ADV Forms and Compliance | Turn Key Hedge Funds - Launch Consultant
00:10:00
GoldSource Mines: Advancing the High-Return Eagle Mountain Gold Project in Guyana

© 2026 Nehu